
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ACRO has released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now and in the future. Decentralized clinical trials (DCTs) have been an innovative resource during the pandemic, and DCTs will continue to be an important, patient-centric clinical trial design.
The DCT Toolkit is now available on ACRO’s website and contains four resources:






